EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Neurofilament Light Chain Predicts Stroke Outcome and is a Potential Marker for Treatment Effects of Neural Stem Cell-derived Extracellular Vesicles in a Rat Stroke Model

Serum-Neurofilament-Leichtkette sagt Schlaganfall-Outcome voraus und ist ein potenzieller Marker für Behandlungseffekte von aus Neuralstemzellen abgeleiteten Extrazellulärvesikeln in einem Ratten-Schlaganfallmodell

Megan K Cannon, Alinde R Fojtik, Charles M White, Raymond L Swetenburg, Steven L Stice, Sean I Savitz, Emily W Baker

Translational Stroke Research · 2026-06 · 17 (3)

DOI: 10.1007/s12975-026-01445-6 ↗

Auf einen Blick

In einem Rattenmodell des akuten ischämischen Schlaganfalls korrelierte Serum-NfL stark mit funktionellen Outcomes. NSC-EV verbesserten das Outcome; die 3-Dosen-Strategie über 48 h schnitt am besten ab.

Fragestellung

Ob Serum-NfL das Schlaganfall-Outcome vorhersagt und als Marker für Behandlungseffekte von NSC-EV im Rattenmodell dienen kann.

Methode

Rattenmodell des akuten ischämischen Schlaganfalls; Vergleich klinischer Serum-Biomarker; Test von NSC-EV in 1-, 2- und 3-Dosen-Regimen über 48 h.

Ergebnisse

Serum-NfL korrelierte stark mit funktionellen Outcomes und war ICAM-1 und S100B überlegen. NfL sagte ebenso gut voraus wie das Infarktvolumen. NSC-EV führten zu kleinerem Infarktvolumen, besserem neurologischem Score und niedrigerem NfL.

Schlussfolgerung der Autor:innen

Die Befunde validieren NfL als artsübergreifenden Biomarker und liefern Dosierungsinformationen für NSC-EV bei AIS.

Kernaussagen

  • Serum-NfL korrelierte stark mit funktionellen Outcomes
  • NfL performte ähnlich wie das Infarktvolumen
  • 3 Dosen NSC-EV über 48 h erzielten die besten Ergebnisse

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, online erschienen am 08.05.2026. Verfasst von Megan K Cannon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aruna Bio Inc, Athens, GA, USA. Hauptthemen laut MEDLINE: Neural Stem Cells, Neurofilament Proteins, Infarction, Middle Cerebral Artery, Extracellular Vesicles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute ischemic stroke (AIS) remains a leading cause of disability worldwide, and effective treatments are urgently needed beyond reperfusion therapy. Translating preclinical success to clinical impact has been hindered by variability in animal models and the lack of translational biomarkers that predict outcomes across species. To overcome these barriers, we developed a robust rat AIS model optimized for consistency and severity, enabling rigorous therapeutic testing. Additionally, we tested a panel of common clinical serum biomarkers to improve translation from rodents to humans. We demonstrated that serum neurofilament light chain (NfL) -a biomarker widely used in clinical stroke studies- strongly correlated with functional outcomes, establishing a translational link that has not been previously reported in rats. Notably, NfL’s predictive capabilities performed as well as infarct volume while outperforming serum biomarkers intercellular adhesion molecule-1 (ICAM-1) and S100 calcium binding protein (S100B). Using this platform, we evaluated the therapeutic impact of neural stem cell-derived extracellular vesicles (NSC EV), a novel biologic therapy poised for clinical trials, on stroke outcome in our rat AIS model. A three-dose regimen of NSC EV over 48 h confirmed our previous studies and produced the best outcomes in stroked animals evidenced by smaller infarct volume, improved neurologic score, and reduced serum NfL. In addition, single-dose and two-dose regimens of NSC EV were both effective at some endpoints. These findings not only validate NfL as a cross-species biomarker but also provide critical dosing insights for NSC EV therapy, accelerating the path from bench to bedside for AIS treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neural Stem CellsNeurofilament ProteinsInfarction, Middle Cerebral ArteryExtracellular VesiclesMaleAnimalsRatsRats, WistarBiomarkersIntercellular Adhesion Molecule-1Disease Models, AnimalWeight LossBrainS100 Calcium Binding Protein beta Subunit

Stichwörter der Autor:innen

BiomarkersIschemic StrokeNeural stem cell derived extracellular vesiclesNeurofilament light chain

Substanzen

neurofilament protein LNeurofilament ProteinsBiomarkersS100b protein, ratIntercellular Adhesion Molecule-1S100 Calcium Binding Protein beta Subunit

Autor:innen und Institutionen

  • Aruna Bio Inc, Athens, GA, USA.
  • Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.
  • Department of Animal and Dairy Science, University of Georgia, Athens, GA, USA.
  • Institute for Stroke and Cerebrovascular Disease, UTHealth-Houston, Houston, TX, USA.
  • Aruna Bio Inc, Athens, GA, USA. ebaker@arunabio.com.

Zitieren

APA

Cannon, M. K., Fojtik, A. R., White, C. M., Swetenburg, R. L., Stice, S. L., Savitz, S. I., & Baker, E. W. (2026). Serum Neurofilament Light Chain Predicts Stroke Outcome and is a Potential Marker for Treatment Effects of Neural Stem Cell-derived Extracellular Vesicles in a Rat Stroke Model. Translational Stroke Research, 17(3). https://doi.org/10.1007/s12975-026-01445-6

Vancouver

Cannon MK, Fojtik AR, White CM, Swetenburg RL, Stice SL, Savitz SI, et al. Serum Neurofilament Light Chain Predicts Stroke Outcome and is a Potential Marker for Treatment Effects of Neural Stem Cell-derived Extracellular Vesicles in a Rat Stroke Model. Translational Stroke Research. 2026;17(3). doi:10.1007/s12975-026-01445-6

BibTeX
@article{Cannon2026,
  author = {Cannon, Megan K and Fojtik, Alinde R and White, Charles M and Swetenburg, Raymond L and Stice, Steven L and Savitz, Sean I and Baker, Emily W},
  title = {Serum Neurofilament Light Chain Predicts Stroke Outcome and is a Potential Marker for Treatment Effects of Neural Stem Cell-derived Extracellular Vesicles in a Rat Stroke Model},
  journal = {Translational Stroke Research},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.1007/s12975-026-01445-6}
}
Kostenlos starten →